A detailed history of First Citizens Bank & Trust CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, First Citizens Bank & Trust CO holds 3,340 shares of EW stock, worth $218,703. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,340
Previous 3,400 1.76%
Holding current value
$218,703
Previous $324,000 4.94%
% of portfolio
0.0%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$84.3 - $94.31 $5,058 - $5,658
-60 Reduced 1.76%
3,340 $308,000
Q1 2024

Apr 15, 2024

SELL
$72.54 - $95.56 $18,135 - $23,890
-250 Reduced 6.85%
3,400 $324,000
Q4 2023

Jan 22, 2024

SELL
$61.71 - $77.76 $160,322 - $202,020
-2,598 Reduced 41.58%
3,650 $278,000
Q3 2023

Oct 30, 2023

BUY
$69.28 - $93.38 $6,997 - $9,431
101 Added 1.64%
6,248 $432,000
Q2 2023

Aug 15, 2023

BUY
$81.41 - $94.33 $12,374 - $14,338
152 Added 2.54%
6,147 $579,000
Q1 2023

May 11, 2023

SELL
$74.26 - $84.51 $4,084 - $4,648
-55 Reduced 0.91%
5,995 $495,000
Q4 2022

Jan 24, 2023

SELL
$68.3 - $87.44 $193,972 - $248,329
-2,840 Reduced 31.95%
6,050 $452,000
Q3 2022

Oct 20, 2022

BUY
$82.37 - $107.29 $185,167 - $241,187
2,248 Added 33.85%
8,890 $735,000
Q2 2022

Jul 26, 2022

SELL
$86.5 - $128.27 $7,266 - $10,774
-84 Reduced 1.25%
6,642 $632,000
Q1 2022

Apr 26, 2022

BUY
$101.96 - $128.34 $37,011 - $46,587
363 Added 5.7%
6,726 $792,000
Q4 2021

Mar 11, 2022

SELL
$106.37 - $130.68 $9,254 - $11,369
-87 Reduced 1.35%
6,363 $824,000
Q3 2021

Oct 15, 2021

SELL
$102.91 - $122.75 $151,174 - $180,319
-1,469 Reduced 18.55%
6,450 $730,000
Q2 2021

Jul 14, 2021

SELL
$83.84 - $104.76 $2,012 - $2,514
-24 Reduced 0.3%
7,919 $820,000
Q1 2021

Apr 14, 2021

BUY
$78.68 - $90.67 $32,809 - $37,809
417 Added 5.54%
7,943 $664,000
Q4 2020

Jan 13, 2021

BUY
$71.69 - $91.23 $38,640 - $49,172
539 Added 7.71%
7,526 $687,000
Q3 2020

Oct 15, 2020

SELL
$67.19 - $87.44 $5,039 - $6,558
-75 Reduced 1.06%
6,987 $558,000
Q2 2020

Jul 15, 2020

BUY
$57.54 - $76.95 $252,312 - $337,425
4,385 Added 163.8%
7,062 $488,000
Q1 2020

Apr 17, 2020

SELL
$52.41 - $81.0 $11,897 - $18,387
-227 Reduced 7.82%
2,677 $505,000
Q3 2019

Oct 18, 2019

SELL
$61.55 - $75.43 $5,047 - $6,185
-82 Reduced 2.75%
2,904 $639,000
Q2 2019

Jul 11, 2019

SELL
$55.74 - $64.41 $50,500 - $58,355
-906 Reduced 23.28%
2,986 $551,000
Q1 2019

Apr 12, 2019

SELL
$47.89 - $64.05 $2,442 - $3,266
-51 Reduced 1.29%
3,892 $745,000
Q4 2018

Jan 15, 2019

BUY
$46.41 - $56.94 $2,459 - $3,017
53 Added 1.36%
3,943 $604,000
Q3 2018

Oct 18, 2018

SELL
$45.7 - $58.03 $274 - $348
-6 Reduced 0.15%
3,890 $677,000
Q2 2018

Jul 11, 2018

BUY
$42.45 - $51.3 $34,809 - $42,066
820 Added 26.66%
3,896 $567,000
Q1 2018

Apr 11, 2018

BUY
$37.19 - $47.45 $4,388 - $5,599
118 Added 3.99%
3,076 $429,000
Q4 2017

Jan 10, 2018

SELL
$33.79 - $39.39 $211,221 - $246,226
-6,251 Reduced 67.88%
2,958 $333,000
Q3 2017

Oct 12, 2017

BUY
$36.29 - $38.83 $334,194 - $357,585
9,209
9,209 $1.01 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track First Citizens Bank & Trust CO Portfolio

Follow First Citizens Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Citizens Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on First Citizens Bank & Trust CO with notifications on news.